01 / Contract Profile
75A50120C00001 Federal Contract Award
Agency code 7505
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50120C00001 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$17.47M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2019 | $59.38M | 1 | — |
| FY 2020 | $97.21M | 1 | +63.7% |
| FY 2021 | $31.62M | 2 | −67.5% |
| FY 2022 | $36.40M | 1 | +15.1% |
| FY 2023 | $808.0K | 2 | −97.8% |
| FY 2024 | $17.47M | 3 | +2,062.3% |
| FY 2025 | $4.96M | 2 | −71.6% |
| FY 2026 | $17.47M | 2 | +252.4% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
PARATEK PHARMACEUTICALS, INC.
UEI D5KEFN62CJ97 · CAGE 80ES6
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $265.32M | 14 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 6505 | DRUGS AND BIOLOGICALS | $265.32M | 14 | 100.0% |
08 / Place of Performance
Where is the work recorded?
BOSTON, SUFFOLK, MASSACHUSETTS, UNITED STATES
ZIP 021163934
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Feb 20, 2026 | P00013 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Feb 19, 2026 | P00012 | $17.47M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Mar 31, 2025 | P00011 | $4.96M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Feb 27, 2025 | P00010 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Dec 11, 2024 | P00009 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Jun 17, 2024 | P00008 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Feb 6, 2024 | P00007 | $17.47M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Nov 29, 2023 | P00006 | $808.0K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Jun 28, 2023 | P00005 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Dec 15, 2022 | P00004 | $36.40M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Sep 23, 2021 | P00003 | $31.57M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Jul 29, 2021 | P00002 | $43.5K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Mar 27, 2020 | P00001 | $97.21M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
| Dec 18, 2019 | Base action | $59.38M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | 6505 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.